Biotech

All Articles

Ventyx's last hope for inflamed med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's ailment medicine did not aid patients obtain remission in a stage 2 tri...

Cognition's phase 2 radiate data blemish Alzheimer's prospect

.Knowledge Therapies' phase 2 luster trial has taken some of the appeal off the Alzheimer's disease ...

BMS axes bispecific months after filing to operate period 3 trial

.Bristol Myers Squibb has possessed a whiplash change of heart on its own BCMA bispecific T-cell eng...

Charles Baum takes control of Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myers...

Asarina to close after attempts to companion Tourette's medicine fail

.After communicating to much more than 200 companies to companion a Tourette syndrome therapy that p...

Novartis markers $150M upfront bispecifics handle Dren Bio

.Novartis has had some rotten luck along with bispecific antitoxins over the last, yet determining d...

AstraZeneca vegetations an EGFR plant along with Pinetree package worth $45M

.Pinetree Therapies will assist AstraZeneca plant some plants in its pipeline along with a brand new...

GRO rounds up $60M collection B to take gout pain therapy right into center

.GRO Biosciences has actually finished the week with an extra $60.3 million in the financial institu...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds CEO

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings and a...